Design, synthesis and biological evaluation of new ionone derivatives as potential neuroprotective agents in cerebral ischemia. 2010

Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
Medicinal & Process Chemistry Division, Central Drug Research Institute, CSIR, Chattar Manzil Palace, Lucknow 226001, UP, India.

A new series of ionone derived allylic alcohols have been evaluated for anti-ischemic activity. Out of them, 12f and 13b decreased infarct volume to 23.98+/-4.7 mm3 and 93.98+/-24.8 mm3 as compared to ischemic group.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
January 2017, Chemical & pharmaceutical bulletin,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
April 2024, Current medicinal chemistry,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
December 2020, Bioorganic & medicinal chemistry letters,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
March 2017, MedChemComm,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
September 2019, European journal of medicinal chemistry,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
December 2020, Naunyn-Schmiedeberg's archives of pharmacology,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
January 2015, Medicinal chemistry (Shariqah (United Arab Emirates)),
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
October 2019, Bioorganic & medicinal chemistry letters,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
May 2016, Bioorganic & medicinal chemistry letters,
Ajay Kumar Srivastava, and Preeti Dohare, and Madhur Ray, and Gautam Panda
February 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!